This guidance was designed to guide the sponsor on safety reporting from study planning and forecasting of anticipated adverse events to the detection of events during the study conduct, the analysis of causality and seriousness, as well as communication of this information to the national competent authorities (NCAs).
It is important to analyse and communicate the benefit risk impact safety relevant information may have on combined studies